What is the effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease?
A systematic literature review by a European panel of experts concluded that enzyme replacement therapy (ERT) has been shown to reduce the risk of stroke, improve neurological signs and symptoms, reduce pain, reduce renal function decline, and improve quality of life in male patients with Fabry disease.